Death Studies,
Journal Year:
2022,
Volume and Issue:
47(5), P. 618 - 623
Published: Aug. 8, 2022
Cannabis
use
has
been
indicated
as
a
risk
factor
for
suicide
in
veterans.
This
study
of
Gulf
War
veterans
tested
the
relationship
between
self-report
past
year
cannabis
and
(a)
suicidal
ideation
(b)
behavior.
Data
were
from
national
sample
(N
=
1126)
Logistic
regression
models
was
associated
with
elevated
behavior,
independent
key
covariates.
In
corroboration
research
on
other
military
populations,
this
indicates
potentially
concerning
association
Indian Journal of Psychiatry,
Journal Year:
2025,
Volume and Issue:
67(3), P. 283 - 302
Published: March 1, 2025
Background:
Cannabis
has
been
associated
with
psychopathology
since
ancient
times,
but
controversies
continue
despite
important
advances
in
the
field.
This
article
is
fourth
one
our
decadal
series
of
review
articles
that
have
providing
an
update
snapshot
meandering
journey
research
findings
this
area.
Aims:
narrative
a
comprehensive
literature
search
over
past
10
years
aims
to
provide
and
current
understanding,
while
raising
unanswered
questions
for
future,
focusing
on
following
areas:
(a)
nosological
changes
cannabis-related
psychiatric
syndromes;
(b)
newer
category
synthetic
cannabinoids;
(c)
cannabis
withdrawal
syndrome);
(d)
psychosis;
(e)
mood
disorders;
(f)
suicidality;
(g)
prenatal
use
offspring;
(h)
effect
recent
liberal
policy
overhaul
control
certain
countries/areas
adverse
outcomes;
(i)
cognition;
(j)
cannabis,
psychopathology,
genetics.
Methods:
The
data
strategies
involved
combination
electronic
databases
manual
hand-searching
relevant
publications
cross-references
using
selected
terms.
primary
focused
Medline
PubMed
Central
extended
such
as
Google
Scholar,
PsychINFO,
Scopus,
Ovid
specific
sections.
Key
references
identified
through
searches
provided
additional
material.
Inclusion
criteria
spanned
studies
published
between
January
2014
June
2024,
more
emphasis
placed
(post-2020)
ensuring
historical
coverage.
Results:
aimed
be
comprehensive,
including
broad
range
without
strict
methodological
exclusions.
Strengths
limitations
cited
are
discussed
when
applicable,
maintaining
consistency
three
prior
reviews.
We
syndromes,
human
(rather
than
animal)
studies,
applied
basic)
research.
only
reference
not
entire
area
because
would
beyond
scope
article.
There
updates
all
areas
covered.
syndromal
entities
ICD-11,
which
also
includes
cannabinoids
first
time.
syndrome
better
characterized.
association
psychosis
robustly
established
especially
very
high-potency
vulnerable
populations,
particularly
young
people.
Work
progress
elucidating
causal
mechanisms.
links
disorders
well
suicidality
cognitive
impairment
characterized,
though
remain.
Recent
liberalizing
policies
produced
accidental
(with
deleterious
effects
offspring)
later
(mixed
findings,
documented
increase
emergency
visits
related
use).
will
require
active
monitoring
new
data.
Conclusion:
field
continues
collect
settle
some
old
questions,
address
view
wide
worldwide
its
implications
public
health.
FOCUS The Journal of Lifelong Learning in Psychiatry,
Journal Year:
2025,
Volume and Issue:
23(2), P. 133 - 140
Published: April 1, 2025
Adolescence
is
a
unique
developmental
period
marked
by
increased
exploration
and
risk-taking,
as
well
important
brain
development
milestones.
Many
people
who
use
substances
will
begin
using
during
adolescence,
cannabis
the
most
commonly
used
illicit
substance
among
adolescents.
For
adolescents
with
mood
disorders,
(and,
extension,
disorder)
even
more
likely,
associated
consequences
are
significant.
In
this
review,
we
explore
assessment
of
disorder
adolescents,
impact
on
symptoms,
level-of-care
recommendations
for
comorbid
effective
treatment
options.
Fortschritte der Neurologie · Psychiatrie,
Journal Year:
2024,
Volume and Issue:
92(09), P. 340 - 346
Published: Feb. 22, 2024
Zusammenfassung
Trends
des
Cannabiskonsums
in
der
Adoleszenz
sollen
von
2016
bis
2023
abgebildet
werden.
Basierend
auf
sieben
Wellen
Präventionsradars,
einer
schulbasierten
epidemiologischen
Studie
Sekundarstufe
I,
wurden
die
Lebenszeit-
und
Monatsprävalenzen
12-bis
17-Jährigen
für
den
Zeitraum
ermittelt.
Der
Auswertung
lagen
54.242
Fragebögen
mit
Angaben
zum
Konsum
Cannabis
zugrunde.
Das
Geschlechterverhältnis
war
ausgeglichen
(50%
weiblich).
durchschnittliche
Alter
betrug
13,9
Jahre
(SD=1,3).
Von
Ausbruch
COVID-19-Pandemie
stieg
Lebenszeitprävalenz
statistisch
bedeutsam
an,
im
ersten
Jahr
Pandemie
sank
sie
signifikant.
Post-pandemisch
hatten
12,3%
(95
%
KI:
11,6-13,1)
Heranwachsenden
mindestens
einmal
ihrem
Leben
konsumiert.
Dieser
Wert
liegt
dem
Niveau
2016.
Die
Monatsprävalenz
lag
2022/2023
bei
3,8%
(95%
3,4-4,3).
Sowohl
als
auch
Jungen
liegen
signifikant
über
Werten
Mädchen.
Angesichts
bekannten
Risiken,
Cannabiskonsum
Jugendalter
einhergehen
können,
ist
es
besorgniserregend,
dass
etwa
jeder
achte
Jugendliche
bereits
experimentiert
hatte.
Konsequente
verhältnis-
verhaltenspräventive
Maßnahmen
sind
erforderlich,
um
Teenageralter
einzudämmen.
Current Neuropharmacology,
Journal Year:
2022,
Volume and Issue:
21(4), P. 911 - 934
Published: July 7, 2022
Bipolar
Disorder
(BD)
is
a
highly
comorbid
condition,
and
rates
of
cooccurring
disorders
are
even
higher
in
youth.
Comorbid
strongly
affect
clinical
presentation,
natural
course,
prognosis,
treatment.This
review
focuses
on
the
treatment
implications
comorbidity
between
BD
Attention-Deficit/Hyperactivity
Disorder,
disruptive
behavior
(Oppositional
Defiant
and/or
Conduct
Disorder),
alcohol
substance
use
disorders,
Autism
Spectrum
anxiety
Obsessive-Compulsive
eating
disorders.These
associations
define
specific
conditions
which
not
simply
sum
different
pictures,
but
occur
as
distinct
complex
combinations
with
developmental
pathways
over
time
selective
therapeutic
requirements.
Pharmacological
treatments
can
improve
these
pictures
by
addressing
conditions,
though
same
may
also
worsen
inducing
manic
or
depressive
switches.The
timely
identification
comorbidities
have
relevant
terms
symptomatology,
outcome.
Specific
studies
pharmacological
management
still
scarce,
information
particularly
lacking
children
adolescents;
for
this
reason,
present
included
conducted
adult
samples.
Developmentally-sensitive
controlled
trials
thus
warranted
to
prognosis
patients,
requiring
finely
personalized
therapies.
Addiction,
Journal Year:
2023,
Volume and Issue:
118(7), P. 1201 - 1215
Published: Feb. 20, 2023
Abstract
Background
and
Aims
The
most
available
data
on
the
prevalence
of
cannabis
use
come
from
population
surveys
conducted
in
high‐income
countries
North
America,
Oceania
Europe.
Less
is
known
about
Africa.
This
systematic
review
aimed
to
summarize
general
population‐level
sub‐Saharan
Africa
since
2010.
Methods
A
comprehensive
search
was
PubMed,
EMBASE,
PsycINFO
AJOL
databases
addition
Global
Health
Data
Exchange
grey
literature
without
language
restriction.
Search
terms
related
‘substance’,
‘Substance‐Related
Disorders’
‘Prevalence’
‘Africa
South
Sahara’
were
used.
Studies
that
reported
selected,
while
studies
clinical
populations
high‐risk
groups
excluded.
Prevalence
adolescents
(10–17
years)
adults
(≥
18
extracted.
Results
study
included
53
for
quantitative
meta‐analysis
13
239
participants.
Among
adolescents,
life‐time,
12‐month
6‐month
7.9%
[95%
confidence
interval
(CI)
=
5.4–10.9%],
5.2%
(95%
CI
1.7–10.3%)
4.5%
3.3–5.8%),
respectively.
corresponding
among
12.6%
6.1–21.2%),
2.2%
1.7–2.7%,
with
only
Tanzania
Uganda)
4.7%
3.3–6.4%),
male‐to‐female
life‐time
relative
risk
1.90
1.25–2.98)
1.67
(CI
0.63–4.39)
adults.
Conclusions
Life‐time
appears
be
approximately
12%
just
under
8%
adolescents.
Nicotine & Tobacco Research,
Journal Year:
2022,
Volume and Issue:
24(10), P. 1684 - 1688
Published: April 13, 2022
Cannabis
use
is
increasing
among
cigarette
smokers
in
the
United
States.
Prior
studies
suggest
that
cannabis
may
be
a
barrier
to
smoking
cessation.
Yet,
extent
which
this
case
adults
seeking
quit
tobacco
remains
unclear.
Tobacco
quitlines
are
most
common
provider
of
no-cost
treatment
for
who
smoke
This
study
investigated
association
between
and
cessation
outcomes
quitline
callers.
Journal of Psychoactive Drugs,
Journal Year:
2023,
Volume and Issue:
56(4), P. 541 - 550
Published: Aug. 8, 2023
The
prevalence
of
depression
and
substance
use
changed
significantly
during
the
COVID-19
pandemic.
present
study
explored
association
between
psychoactive
substances
in
Brazilian
university
students.
This
cross-sectional
was
conducted
2021
2022.
A
sample
1271
students
were
assessed
using
Patient
Health
Questionnaire-9
(PHQ-9)
Alcohol,
Smoking
Substance
Involvement
Screening
Test
(ASSIST).
Hierarchical
multivariate
logistic
regression
models
used
to
assess
tobacco
use,
alcohol
consumption,
illicit
depression.
Among
participants,
424
(33.4%;
95%CI
30.7-36)
screened
positive
for
(PHQ-9
≥
10).
Alcohol
most
consumed
substance.
Recent
associated
with
(adjusted
odds
ratio
[aOR]
1.59;
CI
1.02-2.50).
pattern
moderate
or
high-risk
(aOR
2.11;
1.31-3.42),
3.40;
2.29-5.06),
1.82;
1.15-2.89)
higher
chances
adjusted
models.
Findings
highlight
importance
implementing
support
mental
health
among
These
policies
are
crucial
addressing
maladaptive
behaviors,
such
as
mitigating
psychological
distress,
depression,
which
has
been
exacerbated
